Pharmaceutical formulation of decitabine

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/706 (2006.01) A61K 47/40 (2006.01) A61P 7/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2589052

The present invention provides pharmaceutical formulations of decitabine or 5- aza-2~-deoxycytidine as well as methods of manufacturing the formulations. In particular, decitabine is formulated with a cyclodextrin compound to stabilize and/or enhance solubility of the drug. Kits and methods for using the pharmaceutical formulations are also provided, including methods of administering decitabine to treat conditions or diseases, such as cancer and hematological disorders.

L'invention concerne des formulations pharmaceutiques de décitabine ou de 5-aza-2'-désoxycytidine, ainsi que des procédés de préparation de ces formulations. Ces formulations de décitabine comprennent notamment un composé de cyclodextrine permettant de stabiliser et/ou d'augmenter la solubilité du médicament. L'invention concerne également des trousses et des méthodes d'utilisation de ces formulations pharmaceutiques, notamment des méthodes d'administration de décitabine pour le traitement d'affections ou de maladies telles que le cancer et les troubles hématologiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical formulation of decitabine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulation of decitabine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation of decitabine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1835583

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.